Nv. Larionov et al., Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration, INT J PHARM, 189(2), 1999, pp. 171-178
The objective of this study is to demonstrate the feasibility of microcapsu
les containing a protein and a proteinase inhibitor in order to allow the o
ral administration of proteic or peptidic drug. Starch/bovine serum albumin
mixed-walled microcapsules were prepared using interfacial cross-linking w
ith terephthaloyl chloride. The microcapsules were loaded with native or am
ino-protected aprotinin by incorporating protease inhibitors in the aqueous
phase during the cross-linking process. Microcapsules can be degraded in t
he presence of alpha-amylase. The influence of the formulation parameters o
n the in vitro release of the inhibitor activity and the protein was studie
d. The protective effect of microcapsules with aprotinin for bovine serum a
lbumin was revealed in vitro. The presence of the native bovine serum album
in was demonstrated after incubation of the microcapsules with aprotinin in
a mixture of alpha-amylase (5.4 U/ml) and trypsin (900 spectrophotometric
BAEE units/ml) for 3 h at 37 degrees C, whereas the protein was completely
degraded in the release medium of the microcapsules without aprotinin. (C)
1999 Elsevier Science B.V. All rights reserved.